Proteoforms of the SARS-CoV-2 nucleocapsid protein are primed to proliferate the virus and attenuate the antibody response (2020)
Attributed to:
Applications of Mass Spectrometry to Membrane Protein Drug Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.10.06.328112
Publication URI: http://dx.doi.org/10.1101/2020.10.06.328112
Type: Preprint